Category : Search result: pharmaceutical fines


Ottawa parking crackdown: 3,000 tickets in 2 months

Bylaw enforcement in Ottawa's trendy Wellington West and Hintonburg neighborhoods has issued a staggering 2,900 parking tickets since March, targeting illegal parking and safety violations with increased patrols.

Pharma Veteran Dr. Andreas Wallnofer Joins Optigo Board

Optigo Biotherapeutics strengthens leadership with renowned pharmaceutical expert Dr. Andreas Wallnofer joining its Board of Directors as the company progresses toward Investigational New Drug (IND) enabling studies.

Top FDA Drug Official Resigns Amid Federal Probe

The FDA's principal deputy commissioner, Dr. Namandjé Bumpus, resigns following federal probe into undisclosed concerns about her conduct, marking significant leadership shakeup.

Kimberly-Clark Buys Tylenol Maker in $48.7B Deal

In a landmark move reshaping the consumer healthcare landscape, Kimberly-Clark announces its acquisition of Kenvue, the company behind Tylenol and other household brands, in a staggering US$48.7 billion transaction that creates a new industry powerhouse.

Ontario man fined for illegal construction dumping

A Sudbury-area resident faces significant penalties after being convicted of dumping construction debris on ecologically sensitive Crown land, highlighting Ontario's crackdown on environmental violations.

Blood Pressure Medication Recall Over Cancer Risk

Health Canada issues urgent recall for specific blood pressure medications containing potentially carcinogenic nitrosamine impurity. Learn which lots are affected and what steps to take.

Boehringer Ingelheim Licenses Novel Autoimmune Treatment

Global pharmaceutical leader Boehringer Ingelheim secures exclusive license from Kyowa Kirin to develop innovative autoimmune disease treatment, targeting conditions like lupus and rheumatoid arthritis with novel therapeutic approach.

Page 3 of 3